Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations (Q67676454)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701292%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

MDMA

0 references

title

Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701292%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations (English)

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

substance-related disorder

2 November 2022

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1701292

history and philosophy of science

2 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

2 November 2022

author name string

G. A. Ricaurte

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1701292

2 November 2022

K. T. Finnegan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1701292

2 November 2022

I. Irwin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1701292

2 November 2022

J. W. Langston

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1701292

2 November 2022

language of work or name

English

0 references

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701292%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1990.tb16919.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1990.tb16919.x/fullpdf

2 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Annals of the New York Academy of Sciences

2 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701292%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

600

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701292%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

699-708; discussion 708-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701292%20AND%20SRC:MED&resulttype=core&format=json

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

16 September 2019

cites work

6

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

2 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain

2 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates

2 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration.

2 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.

2 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Neurotransmission and the experience of low back pain; no association between CSF monoamine metabolites and pain

2 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Some behavioral effects of serotonin depletion depend on method: a comparison of 5,7-dihydroxytryptamine, p-chlorophenylalanine, p-choloroamphetamine, and electrolytic raphe lesions

2 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Behavioral effects of serotonin neurotoxins: an overview

2 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation.

2 November 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Intranasal vasotocin decreases cerebrospinal fluid 5-HIAA levels in man.

2 November 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Cerebrospinal fluid parameters in healthy volunteers during serial lumbar punctures

2 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.

2 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites

2 November 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain

2 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Tryptophan and 5-hydroxyindoleacetic acid in human cerebrospinal fluid.

2 November 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Biogenic Amine Metabolites in Cerebrospinal Fluid of Depressed and Manic Patients

2 November 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?

2 November 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

2 November 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes

2 November 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Psychomotor Activity and Cerebrospinal Fluid Amine Metabolites in Affective Illness

2 November 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man.

2 November 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates

2 November 2022

34

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies

2 November 2022

35

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

5-hydroxyindoleacetic cid in spinal fluid: relative contribution from brain and spinal cord.

2 November 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Correlations between aminergic metabolites simultaneously obtained from human CSF and brain.

2 November 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Biochemical evidence of selective nerve cell changes in the normal ageing human and rat brain.

2 November 2022

38

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Effect of age on human brain serotonin (S-1) binding sites

2 November 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys

2 November 2022

40

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1990.TB16919.X

2 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701292%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference